Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruptionMÜLLER, F.-M. C; WERNER, K. E; KASAI, M et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 6, pp 1625-1629, issn 0095-1137Article

Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensisMÜLLER, F.-M. C; KURZAI, O; HACKER, J et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 48, Num 5, pp 713-715, issn 0305-7453Article

The rationale and method for constructing internal control DNA used in pertussis polymerase chain reactionMÜLLER, F.-M. C; SCHNITZLER, N; CLOOT, O et al.Diagnostic microbiology and infectious disease. 1998, Vol 31, Num 4, pp 517-523, issn 0732-8893Article

Fortschritte in Prävention und Therapie infektiöser Komplikationen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Advances in prevention and treatment of infectious complications in children and adolescents with cancerGROLL, A. H; MÜLLER, F.-M. C.Klinische Pädiatrie. 1998, Vol 210, Num 3, pp 106-114, issn 0300-8630Article

Lipid formulations of Amphotericin B : Clinical perspectives for the management of invasive fungal infections in children with cancer : Infektionen und supportive Therapie = Infections and supportive therapyGROLL, A. H; MÜLLER, F.-M. C; PISCITELLI, S. C et al.Klinische Pädiatrie. 1998, Vol 210, Num 4, pp 264-273, issn 0300-8630Conference Paper

Laboratory diagnosis of pertussis : State of the art in 1997MÜLLER, F.-M. C; HOPPE, J. E; VON KÖNIG, A. C.-H. W et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 10, pp 2435-2443, issn 0095-1137Article

Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyrGIL-LAMAIGNERE, C; MÜLLER, F.-M. C.International journal of antimicrobial agents. 2004, Vol 23, Num 5, pp 520-523, issn 0924-8579, 4 p.Article

Empfehlungen zur Prävention der Pneumocystis-carinii-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A38-A49, issn 0300-8630, SUP1Article

Prävention von Pilzinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Prevention of fungal infections in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A50-A68, issn 0300-8630, SUP1Article

Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virusMÜLLER, F.-M. C; GROLL, A. H; WALSH, T. J et al.European journal of pediatrics. 1999, Vol 158, Num 3, pp 187-199, issn 0340-6199Article

Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasisMÜLLER, F.-M. C; KASAI, M; FRANCESCONI, A et al.Journal of clinical microbiology (Print). 1999, Vol 37, Num 10, pp 3405-3408, issn 0095-1137Article

Pulmonary Cryptococcosis associated with Cryptococcal Meningitis in non-AIDS PatientsZHU, Li-Ping; SHI, Yao-Zhong; WENG, Xin-Hua et al.Mycoses. 2002, Vol 45, Num 3-4, pp 111-117, issn 0933-7407Article

Combined surgical and antifungal treatment of a subcutaneous infection due to Paecilomyces lilacinusKURZAI, O; VAETH, T; HAMELMANN, W et al.Medical mycology (Oxford. Print). 2003, Vol 41, Num 3, pp 253-258, issn 1369-3786, 6 p.Article